Novartis Investigative Site

Beijing, Chaoyang 100021

1 studies enrolling now · 1 studies all time

What they study most

Metastatic Hormone-sensitive Prostate Cancer

Studies at this site

• An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) — Recruiting now